Exin Therapeutics vs Duckie

Side-by-side comparison of AI visibility scores, market position, and capabilities

Exin Therapeutics leads in AI visibility (35 vs 25)

Exin Therapeutics

EmergingHealthcare

General

SF AI neurotherapeutics discovery platform for epilepsy/autism/Parkinson's with multimodal neural AI; animal lab + proof-of-concept + 2 patents in 1.5 months; $25M Philippines lab investment competing with Recursion for AI-driven CNS gene therapy.

AI VisibilityBeta
Overall Score
D35
Category Rank
#1006 of 1167
AI Consensus
61%
Trend
stable
Per Platform
ChatGPT
35
Perplexity
43
Gemini
26

About

Exin Therapeutics is a San Francisco-based AI-powered neurotherapeutics drug discovery company — pioneering genetic therapies that target neural activity to treat epilepsy, autism spectrum disorder symptoms, Parkinson's disease, and other neurological conditions using a multimodal AI platform that predicts therapeutic candidate potential across multiple neural disorders simultaneously. Using neural activity recordings, behavioral assays, and transcriptomics data as inputs, Exin's AI models identify genetic intervention targets and predict therapeutic outcomes before entering animal studies — compressing the target identification timeline that traditional neuroscience drug discovery requires. The company established an animal research facility, obtained proof-of-concept results in mice, and filed two provisional patents within 1.5 months of San Francisco operations, and is investing approximately $25 million to build the Philippines' first neurotherapeutics laboratory.

Full profile

Duckie

EmergingInfrastructure

IT Operations

SF YC W24 AI support agent builder at 80% resolution time reduction and 71% ticket deflection; $500K from a16z/Greylock/YC/Netflix competing with Intercom Fin for customer support AI workflow automation.

AI VisibilityBeta
Overall Score
D25
Category Rank
#18 of 68
AI Consensus
59%
Trend
stable
Per Platform
ChatGPT
33
Perplexity
19
Gemini
36

About

Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 additional investors — providing customer support teams with an AI agent builder that translates existing support processes and workflows into predictable, reliable AI automation, achieving 80% reduction in resolution time and 71% ticket deflection for deployed teams. Founded in 2023 and targeting customer support leaders at growth-stage software companies, Duckie enables support teams to deploy AI agents in minutes without engineering dependency.

Full profile

AI Visibility Head-to-Head

35
Overall Score
25
#1006
Category Rank
#18
61
AI Consensus
59
stable
Trend
stable
35
ChatGPT
33
43
Perplexity
19
26
Gemini
36
31
Claude
31
30
Grok
34

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.